Activation of pp60(c-src) is necessary for human vascular smooth muscle cell migration

Surgery

Volumn 122, Issue 2, 1997, Pages 138-145

  Mureebe, Leila ^a   Nelson, Peter R ^a   Yamamura, Shinji ^a   Lawitts, Joel ^a   Kent, K Craig ^a,b  

^a HARVARD MEDICAL SCHOOL   (United States)

^b WEILL CORNELL MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN KINASE P60; IMMUNOGLOBULIN G; PLATELET DERIVED GROWTH FACTOR; PLATELET DERIVED GROWTH FACTOR A; PLATELET DERIVED GROWTH FACTOR BB; PLATELET-DERIVED GROWTH FACTOR A; PLATELET-DERIVED GROWTH FACTOR BB;

ARTERY INTIMA PROLIFERATION; AUTOPHOSPHORYLATION; CELL MIGRATION; CHEMOTAXIS; CONFERENCE PAPER; ENZYME ACTIVITY; ENZYME SPECIFICITY; HEMATOPOIETIC CELL; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN DOMAIN; QUALITY OF LIFE; SEQUENCE HOMOLOGY; SMOOTH MUSCLE FIBER; VASCULAR SMOOTH MUSCLE; ARTICLE; CELL CULTURE; DRUG EFFECT; ENZYME ACTIVATION; ENZYMOLOGY; IMMUNOLOGY; METABOLISM; PHYSIOLOGY; SAPHENOUS VEIN; SIGNAL TRANSDUCTION;

CELLS, CULTURED; CHEMOTAXIS; ENZYME ACTIVATION; HUMANS; IMMUNOGLOBULIN G; MUSCLE, SMOOTH, VASCULAR; PLATELET-DERIVED GROWTH FACTOR; PROTO-ONCOGENE PROTEINS PP60(C-SRC); SAPHENOUS VEIN; SIGNAL TRANSDUCTION;

EID: 0031201734     PISSN: 00396060     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0039-6060(97)90002-7     Document Type: Conference Paper

References (25)

1. Donaldson MC, Mannick JA, Whittemorc AD. Causes of primary graft failure after in situ saphenous vein bypass grafting. J Vasc Surg 1992;15:113-20.
2. Chervu A, Moore WS. An overview of intimai hyperplasia. Surg Gynecol Obstet 1990:433-40.
3. Ross R. The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature 1993:801-9.
4. Superti-Furga G, Courtneidge SA. Structure-function relationships in src family and related protein tyrosine kinases. Bioassays 1995;17:321-30.
5. Park J, Cartwright CA. Src activity increases and Yes activity decreases during mitosis of human colon carcinoma cells. Mol Cell Biol 1995;15:2374-82.
6. Roche S, Koegl M, Barrone V, Roussel MF, Courtneidge SA. DNA synthesis induced by some but not all growth factors requires src family protein tyrosine kinases. Mol Cell Biol 1995;15:1102-9.
7. Twamley-Stein GM, Pepperkok R, Ansorge W, Courtneidge SA. The src family tyrosine kinases are required for platelet-derived growth factor-mediated signal transduction in NIH 3T3 cells. Proc Natl Acad Sci U S A 1993;90:696-700.
8. c-src antibodies inhibits the angiotensin II activation of phospholipase C-γ1 in rat aortic smooth muscle cells. J Biol Chem 1995;270:15734-8.
9. Mii S, Khalil RA, Morgan KG, Ware JA, Kent KC. Mitogen-activated protein kinase and proliferation of human vascular smooth muscle cells. Am J Physiol 1996;270:H142-50.
10. Hogan B, Beddington R, Costantini F, Lacy E. Manipulating the mouse embryo: a laboratory manual. 2nd ed. Plainview (NY): Cold Spring Harbor Laboratory Press; 1994.
11. cdc2 is a specific and efficient substrate of src-family tyrosine kinases. J Biol Chem 1992;267:9248-56.
12. Jiang B, Yamamura S, Nelson PR, Mureebe L, Kent KC. Differential effects of platelet-derived growth factor isotypes on human smooth muscle cell proliferation and migration are mediated by distinct signaling pathways. Surgery 1996;120:427-32.
13. Kypta RM, Goldberg Y, Ulug ET, Courtneidge SA. Association between the PDGF receptor and members of the src family of tyrosine kinases. Cell 1990;62:481-92.
14. Chen YH, Pouyssegur J, Courtneidge SA, Van Obberghen-Schilling E. Activation of Src family kinase activity by the G protein-coupled thrombin receptor in growth-responsive fibroblasts. J Biol Chem 1994;269:27372-7.
15. Weernink PA, Rijksen G. Activation and translocation of c-Src to the cytoskeleton by both platelet-derived growth factor and epidermal growth factor. J Biol Chem 1995;270:2264-7.
16. Heldin CH, Ostman A, Eriksson A, Siegbahn A, Claesson-Welsh L, Westermark B. Platelet-derived growth factor: isoform-specific signalling via heterodimeric or homodimeric receptor complexes. Kidney Int 1992;41:571-4.
17. Ralston R, Bishop JM. The product of the protooncogene c-src is modified during the cellular response to platelet-derived growth factor. Proc Natl Acad Sci U S A 1985;82:7845-9.
18. c-src and increases its protein-tyrosine kinase activity. Mol Cell Biol 1988;8:3345-56.
19. Garfinkel S, Hu X, Prudovsky IA, McMahon GA, Kapnik EM, McDowell SD, et al. FGF-1-dependent proliferative and migratory responses are impaired in senescent human umbilical vein endothelial cells and correlate with the inability to signal tyrosine phosphorylation of fibroblast growth factor receptor-1 substrates. J Cell Biol 1996;134:783-91.
20. c-src expression. J Clin Invest 1992;89:315-20.
21. c-src from the plasma membrane to the cytosol after stimulation by platelet-derived growth factor. J Biol Chem 1993;268:19552-8.
22. c-src alters a selective morphogenetic property of epithelial cells in vitro without a mitogenic effect. Mol Cell Biol 1988;8:632-46.
23. Calalb MB, Polte TR, Hanks SK. Tyrosine phosphorylation of focal adhesion kinase at sites in the catalytic domain regulates kinase activity: a role for Src family kinases. Mol Cell Biol 1995;15:954-63.
24. Thomas SM, Soriano P, Imamoto A. Specific and redundant roles of Src and Fyn in organizing the cytoskeleton. Nature 1995;376:267-71.
25. Erpel T, Courtneidge SA. Src family protein tyrosine kinases and cellular signal transduction pathways. Curr Opin Cell Biol 1995;7:176-82.